Signal Transduction Mechanisms: Messengers and Receptors

Overview of Intercellular Communication

Cells communicate with each other through chemical messengers that bind to specific receptors on target cells. This process is essential for coordinating cellular activities and responses to environmental changes.

• Regulatory chemical messengers are secreted by one cell and detected by receptors on another, sometimes distant, cell.

• Receptors can be located on the cell surface or inside the cell, depending on the nature of the signaling molecule.

Classification of Signaling Molecules

Signaling molecules are classified based on the distance between the site of production and the target cell:

• Endocrine signals: Produced far from target tissues and travel via the circulatory system (e.g., hormones).

• Paracrine signals: Diffusible signals that act over a short range between neighboring cells.

• Juxtacrine signals: Require direct physical contact between the sending and receiving cells.

• Autocrine signals: Act on the same cell that produces them.

Ligands and Receptors

When a messenger (ligand) reaches its target, it binds to a specific receptor, initiating a cellular response.

• Ligand: The primary messenger that binds to a receptor, which may be on the cell surface or inside the cell.

• Ligand binding can trigger the production of second messengers (small molecules or ions that relay signals within the cell).

• This process often initiates a signal transduction cascade leading to changes in cell behavior or gene expression.

Specificity and Affinity of Ligand-Receptor Interactions

Ligands bind to receptors with high specificity, similar to enzyme-substrate interactions.

• The binding site on the receptor fits the ligand closely, involving several non-covalent bonds.

• The cognate receptor is specific for a particular ligand.

• Receptor affinity is quantified by the dissociation constant ():

is the concentration of free ligand at which half the receptors are occupied.

• High affinity receptors have low values.

Agonists and Antagonists

• Agonists: Synthetic or natural ligands that activate receptors.

• Antagonists: Bind receptors without activating them, blocking the action of natural ligands.

• Example: Famotidine and cimetidine are antagonists that reduce stomach acid by blocking histamine receptors.

Receptor Desensitization

Cells adapt to persistent stimulation by reducing their response to ligands, a process called receptor desensitization.

• Can involve receptor-mediated endocytosis (reducing receptor density on the surface).

• Alterations to the receptor (e.g., phosphorylation) can lower its affinity for the ligand.

Coreceptors

• Coreceptors are cell surface proteins that assist in ligand-receptor interactions, enhancing signal transduction.

Signal Amplification

Signal amplification allows small amounts of ligand to produce large cellular responses.

• Each step in a signaling cascade can activate multiple downstream molecules, multiplying the effect.

Categories of Receptors

• Ligand-gated channels

• G protein-linked receptors (GPCRs)

• Protein kinase-associated receptors

G Protein-Linked Receptors (GPCRs)

GPCRs are a large family of receptors that activate G proteins upon ligand binding.

• Characterized by seven transmembrane α-helices.

• Ligand binding causes a conformational change, activating a specific G protein.

Structure and Function of G Proteins

• Two types: Heterotrimeric G proteins (Gα, Gβ, Gγ subunits) and small monomeric G proteins (e.g., Ras).

• G proteins act as molecular switches, active when bound to GTP and inactive when bound to GDP.

• Activation involves exchange of GDP for GTP on the Gα subunit, which then dissociates from Gβγ.

• Gα or Gβγ can initiate downstream signaling, often by modulating second messenger production.

Regulation and Inactivation of G Proteins

• G proteins are inactivated when Gα hydrolyzes GTP to GDP, often accelerated by GTPase activating proteins (GAPs) or regulators of G protein signaling (RGS).

Second Messengers: cAMP

• Cyclic AMP (cAMP) is synthesized from ATP by adenylyl cyclase, which is activated by Gαs and inhibited by Gαi.

• cAMP activates protein kinase A (PKA), which phosphorylates target proteins on serine or threonine residues.

• cAMP is degraded by phosphodiesterase, ensuring transient signaling.

Clinical Relevance

• Cholera toxin (from Vibrio cholerae) locks Gαs in the active state, causing excessive cAMP production and severe dehydration.

• Pertussis toxin (from Bordetella pertussis) inactivates Gαi, leading to unregulated cAMP production and respiratory symptoms.

Other Second Messengers: IP3 and DAG

• Phospholipase C (PLC) cleaves PIP2 into inositol-1,4,5-trisphosphate (IP3) and diacylglycerol (DAG).

• IP3 triggers Ca2+ release from the endoplasmic reticulum by binding to IP3 receptor channels.

• DAG, together with Ca2+, activates protein kinase C (PKC).

Calcium as a Second Messenger

• Intracellular Ca2+ is tightly regulated by pumps and channels.

• Ca2+ release can be triggered by IP3 or ryanodine receptors (important in muscle contraction).

• Calcium signals are monitored using fluorescent dyes (calcium indicators).

• Calcium release is crucial in processes such as egg fertilization and activation of metabolic pathways.

Calmodulin

• Calmodulin is a calcium-binding protein that undergoes a conformational change upon binding Ca2+, allowing it to regulate various target proteins.

Protein Kinase-Associated Receptors

These receptors possess intrinsic kinase activity or associate with kinases, transmitting signals via phosphorylation cascades.

• Two major classes: Tyrosine kinases and serine/threonine kinases.

Growth Factors and Receptor Tyrosine Kinases (RTKs)

• Growth factors (e.g., PDGF, insulin, EGF) bind RTKs, stimulating cell growth and division.

• RTKs are single-pass transmembrane proteins with extracellular ligand-binding and cytosolic kinase domains.

• Ligand binding induces receptor dimerization and autophosphorylation on tyrosine residues.

RTK Signaling Pathways

• Phosphorylated RTKs recruit proteins with SH2 domains (e.g., GRB2), initiating downstream signaling.

• Ras is a small G protein activated by RTKs via the GEF Sos, leading to a kinase cascade (Raf → MEK → MAPK).

• MAPKs phosphorylate transcription factors (e.g., Jun, Ets), altering gene expression for growth and division.

Inactivation and Mutations of RTKs

• Ras is inactivated by GTP hydrolysis, facilitated by GAPs.

• Dominant negative mutations in RTKs can block normal signaling; constitutively active mutations can cause uncontrolled signaling (e.g., achondroplasia from FGFR-3 mutation).

RTKs Activate Additional Pathways

• RTKs can activate PLCγ (via SH2 domain), leading to IP3 and DAG production.

• They can also activate PI 3-kinase, which phosphorylates phosphatidylinositol lipids, affecting diverse cellular processes.

Receptor Serine-Threonine Kinases and TGFβ Signaling

• Transforming growth factor β (TGFβ) family signals through receptor serine-threonine kinases.

• Ligand binding causes type II receptor to phosphorylate type I receptor, which then phosphorylates Smad proteins.

• Phosphorylated Smads form complexes that enter the nucleus to regulate gene expression.

• Pathway is terminated by Smad degradation or export from the nucleus.

Signal Integration and Crosstalk

• Scaffolding proteins (e.g., Ksr) organize signaling complexes for efficient signal transduction.

• Signaling pathways can interact (crosstalk), allowing integration of multiple signals.

• Example: Yeast mating involves GPCR-mediated signaling and cell fusion.

Hormone Signaling

• Hormones are secreted chemical signals used by plants and animals for long-distance communication.

• Animal hormones are classified as amino acid derivatives, peptides, proteins, or lipid-like steroids.

Adrenergic Hormones and Receptors

• Epinephrine and norepinephrine mediate the "fight or flight" response, increasing cardiac output and mobilizing energy stores.

• Bind to adrenergic receptors (α and β types), which are GPCRs associated with different G proteins.

• α1-adrenergic receptors (Gq) activate PLC (IP3 and DAG pathway); β-adrenergic receptors (Gs) activate adenylyl cyclase (cAMP pathway).

Control of Glycogen Metabolism

• cAMP activates PKA, which phosphorylates and activates phosphorylase kinase, converting glycogen phosphorylase to its active form and promoting glycogen breakdown.

• PKA also phosphorylates and inactivates glycogen synthase, inhibiting glycogen synthesis.

Insulin Signaling and Glucose Regulation

• Insulin (a peptide hormone) lowers blood glucose by stimulating uptake and storage in muscle and adipose tissue.

• Insulin binds to its RTK, leading to phosphorylation of IRS-1, which activates both the Ras pathway and PI 3-kinase pathway.

• PI 3-kinase converts PIP2 to PIP3, which activates Akt (protein kinase B).

• Akt promotes glucose uptake (via GLUT4 translocation) and glycogen synthesis (by inhibiting GSK3).

Diabetes

• Type I diabetes: Loss of insulin-producing cells; treated with insulin.

• Type II diabetes: Insulin resistance; not effectively treated with insulin.

Steroid Hormone Receptors

• Steroid hormones (e.g., estrogen, testosterone) are lipid-soluble and act via intracellular receptors, primarily in the nucleus.

• Hormone-receptor complexes regulate transcription of target genes.

Summary Table: Major Classes of Cell Surface Receptors

Key Equations

• Dissociation constant ():

• cAMP formation:

\text{ATP} \xrightarrow{\text{adenylyl cyclase}} \text{cAMP} + \text{PP}_i

• Glycogen breakdown:

\text{Glycogen} + \text{Pi} \xrightarrow{\text{glycogen phosphorylase}} \text{Glucose-1-phosphate}

Summary

• Cell signaling involves a complex network of messengers, receptors, and intracellular pathways.

• Specificity, amplification, and regulation are key features of signal transduction.

• Disruptions in signaling pathways can lead to diseases such as diabetes and cancer.

Additional info: Some explanations and examples were expanded for clarity and completeness, including the summary table and equations.